Analgesics in China

  • ID: 224154
  • Report
  • Region: Asia, China
  • 18 pages
  • Euromonitor International
1 of 4
The rapidly ageing population in China continued to drive demand for analgesics, particularly topical analgesics/anaesthetic, in 2017. The elderly commonly suffer from aches and pains caused by conditions such as arthritis and rheumatism, thus resulting in the long-term usage of analgesics, which are readily available in chemists/pharmacies. As a result, analgesics continued to record steady current value growth in 2017. As population ageing in China accelerates over the forecast period, analges...

The publisher's Analgesics in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 4
ANALGESICS IN CHINA

October 2017

LIST OF CONTENTS AND TABLES

Headlines
Prospects
Rapidly Ageing Population and Modern Lifestyles Drive Demand for Analgesics
Rx To OTC Switches Help A Mature Category To Maintain Stable Growth
Competitive Landscape
Yunnan Baiyao Group Maintains Its Leading Position
Domestic Players Remain Dominant While International Companies Continue To Lose Share
Category Data
Table 1 Sales of Analgesics by Category: Value 2012-2017
Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
Executive Summary
Consumer Health Continues To Perform Well
Healthcare Reform Policies Heavily Impact the Industry
Mergers and Acquisitions Reshape the Competitive Landscape
Omni-channel Distribution Is Emerging in Consumer Health
Stable Growth Anticipated
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 9 Life Expectancy at Birth 2012-2017
Market Data
Table 10 Sales of Consumer Health by Category: Value 2012-2017
Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 14 Distribution of Consumer Health by Format: % Value 2012-2017
Table 15 Distribution of Consumer Health by Format and Category: % Value 2017
Table 16 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches 2016-2017
Definitions
Sources
Summary 2 Research Sources
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll